|
Volumn 13, Issue 5, 2007, Pages 534-535
|
Assessment of biomarker expression in predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
DOCETAXEL;
DOXORUBICIN;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER PATIENT;
CANCER SURGERY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
MULTIPLE CYCLE TREATMENT;
TREATMENT RESPONSE;
BCL-2-ASSOCIATED X PROTEIN;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
KI-67 ANTIGEN;
NEOADJUVANT THERAPY;
|
EID: 34548252289
PISSN: 1075122X
EISSN: 15244741
Source Type: Journal
DOI: 10.1111/j.1524-4741.2007.00483.x Document Type: Letter |
Times cited : (5)
|
References (4)
|